Published in J Gen Virol on August 01, 1979
Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship. J Virol (2004) 2.01
Electrorotation studies of baby hamster kidney fibroblasts infected with herpes simplex virus type 1. Biophys J (1999) 1.06
Electrical response of a B lymphoma cell line latently infected with Kaposi's sarcoma herpesvirus. Biosens Bioelectron (2016) 0.75
Characterization of the envelope proteins of pseudorabies virus. J Virol (1984) 3.57
Pathway of assembly of herpesvirus capsids: an analysis using DNA+ temperature-sensitive mutants of pseudorabies virus. Virology (1982) 2.99
DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res (1988) 2.39
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology (1986) 2.26
Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol (1999) 1.93
Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents. J Gen Virol (1979) 1.92
Lack of association of herpesviruses with brain tumors. J Neurovirol (2006) 1.88
Entry of poliovirus type 1 and Mouse Elberfeld (ME) virus into HEp-2 cells: receptor-mediated endocytosis and endosomal or lysosomal uncoating. J Gen Virol (1985) 1.82
Induction of mutations within the host cell genome by partially inactivated herpes simplex virus type 1. Virology (1982) 1.74
Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology (1987) 1.73
Ribosomal components from Escherichia coli 50 S subunits involved in the reconstitution of peptidyltransferase activity. J Biol Chem (1981) 1.68
Viruses in the etiology of human genital cancer. Prog Med Virol (1984) 1.54
Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17. J Virol (1992) 1.45
Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins. J Gen Virol (1990) 1.43
Detection of infectious adeno-associated virus particles in human cervical biopsies. Virology (1998) 1.30
Inhibition of initiator-induced SV40 gene amplification in SV40-transformed Chinese hamster cells by infection with a defective parvovirus. Int J Cancer (1983) 1.23
Recovery of structurally intact and infectious poliovirus type 1 from HeLa cells during receptor-mediated endocytosis. Virology (1989) 1.23
Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol (1994) 1.14
Iodination of poliovirus capsid proteins. J Gen Virol (1977) 1.13
50-S subunit from Escherichia coli ribosomes. Isolation of active ribosomal proteins and protein complexes. Eur J Biochem (1979) 1.08
Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium. J Gen Virol (1997) 1.07
Selective DNA-amplification induced by carcinogens (initiators): evidence for a role of proteases and DNA polymerase alpha. Int J Cancer (1985) 1.06
Selective killing of carcinogen-treated SV40-transformed Chinese hamster cells by a defective parvovirus. Virology (1984) 1.03
Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion. Arch Virol (1986) 1.00
Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int (1989) 0.98
Human genital tissues containing DNA of adeno-associated virus lack DNA sequences of the helper viruses adenovirus, herpes simplex virus or cytomegalovirus but frequently contain human papillomavirus DNA. J Gen Virol (1997) 0.98
Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells. Virology (1984) 0.98
Beta 2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem Hoppe Seyler (1987) 0.98
Evidence for infection of the human embryo with adeno-associated virus in pregnancy. Hum Reprod (1999) 0.97
Herpes simplex virus-induced amplification of SV40 sequences in transformed Chinese hamster embryo cells. Int J Cancer (1983) 0.96
Internalization of human rhinovirus 14 into HeLa and ICAM-1-transfected BHK cells. Med Microbiol Immunol (1997) 0.96
Oncolytic potential of rodent parvoviruses for cancer therapy in humans: a brief review. J Vet Med B Infect Dis Vet Public Health (2005) 0.95
Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection. Int J Cancer (1998) 0.95
Transformation of human cells by oncogenic viruses supports permissiveness for parvovirus H-1 propagation. J Virol (1989) 0.94
Processing of pseudorabies virus glycoprotein gII. J Virol (1990) 0.94
Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41. Clin Exp Immunol (1993) 0.94
Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection. AIDS (1997) 0.93
Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea. AIDS Res Hum Retroviruses (1997) 0.92
NF kappa B upstream regulatory sequences of the HIV-1 LTR are involved in the inhibition of HIV-1 promoter activity by the NS proteins of autonomous parvoviruses H-1 and MVMp. Virology (1993) 0.92
Amplification of bovine papillomavirus DNA by N-methyl-N'-nitro-N-nitrosoguanidine, ultraviolet irradiation, or infection with herpes simplex virus. Virology (1989) 0.92
Persistence of parvovirus H-1 DNA in human B- and T-lymphoma cells. Virus Res (1990) 0.91
Induction of differentiation-associated changes in established human cells by infection with adeno-associated virus type 2. J Virol (1992) 0.91
Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J Virol Methods (1998) 0.91
Dense particles and slow sedimenting particles produced by ultraviolet irradiation of poliovirus. J Gen Virol (1983) 0.91
Specific cross-linking of capsid proteins to virus RNA by ultraviolet irradiation of poliovirus. J Gen Virol (1982) 0.90
Entry of pseudorabies virus into CHO cells is blocked at the level of penetration. Arch Virol (1990) 0.89
Adeno-associated virus sensitizes HeLa cell tumors to gamma rays. J Virol (1992) 0.89
Detection of adeno-associated virus in human semen: does viral infection play a role in the pathogenesis of male infertility? Fertil Steril (1999) 0.89
Update on HIV-1 group O infection in Equatorial Guinea, Central Africa. AIDS (1997) 0.88
Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Am J Epidemiol (1992) 0.88
Reduction of 51Cr-permeability of tissue culture cells by infection with herpes simplex virus type 1. Intervirology (1979) 0.87
Adeno-associated virus type 2 interferes with early development of mouse embryos. J Gen Virol (1994) 0.87
HSV- and chemical carcinogen-induced amplification of SV40 DNA sequences in transformed cells is cell-line-dependent. Int J Cancer (1985) 0.86
Functions of the major nonstructural DNA binding protein of a herpesvirus (pseudorabies). Virology (1983) 0.85
A peptide-model for the heparin-binding property of pseudorabies virus glycoprotein III. Med Microbiol Immunol (1993) 0.85
Detection of respiratory virus antigens in nasopharyngeal secretions from patients with acute respiratory disease by radio-immunoassay and tissue culture isolation. Med Microbiol Immunol (1984) 0.84
DNA of adeno-associated virus (AAV) in testicular tissue and in abnormal semen samples. Hum Reprod (2001) 0.84
Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISA. Infection (1987) 0.83
Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers. Virus Res (1999) 0.83
Sequence of gp41env immunodominant region of HIV type 1 group O from west central Africa. AIDS Res Hum Retroviruses (1997) 0.83
Biological activity of N-nitrosodiethanolamine and of potential metabolites which may arise after activation by alcohol dehydrogenase in Salmonella typhimurium, in mammalian cells, and in vivo. J Cancer Res Clin Oncol (1986) 0.82
Cellular receptor structures for pseudorabies virus are blocked by antithrombin III. Med Microbiol Immunol (1995) 0.82
Hemodynamics during hemodialysis, sequential ultrafiltration and hemofiltration. J Dial (1979) 0.82
Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? Nephrol Dial Transplant (1998) 0.82
Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klin Wochenschr (1988) 0.81
Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients? Clin Nephrol (2000) 0.81
HIV-1 detection in endocervical swabs and mode of HIV-1 infection. Lancet (1994) 0.81
Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia. Clin Nephrol (2002) 0.81
Glycoprotein B (gB) of pseudorabies virus interacts specifically with the glycosaminoglycan heparin. Virus Res (1996) 0.81
Adeno-associated virus DNA in human gestational trophoblastic disease. Placenta (2002) 0.81
Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma. J Med Virol (2001) 0.80
Correlation between poliomyelitisvirus-reproduction-cycle, chromosomal alterations and lysosomal enzymes. Arch Gesamte Virusforsch (1969) 0.80
Sero-epidemiological analysis of the risk of virus infections for childhood leukaemia. Int J Cancer (1996) 0.80
Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia. Int J Cancer (2001) 0.80
Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia. Clin Nephrol (2000) 0.79
Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2. Eur J Cancer (1999) 0.79
Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced methotrexate and adriamycin resistance in CHO cells by adeno-associated virus type 2. Int J Cancer (1990) 0.79
Chromosomal damage after infection with poliomyelitis virus. Exp Cell Res (1967) 0.78
Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology (1995) 0.78
Oxidative stress in cardio renal anemia syndrome: correlations and therapeutic possibilities. Clin Nephrol (2003) 0.78
Electroencephalogram investigations of the disequilibrium syndrome during bicarbonate and acetate dialysis. Proc Eur Dial Transplant Assoc (1983) 0.78
alpha-Ketoglutarate application in hemodialysis patients improves amino acid metabolism. Nephron (1996) 0.78
Advantages of bicarbonate hemodialysis. Artif Organs (1982) 0.78
Genotoxic activities of benzamidine and its N-hydroxylated metabolite benzamidoxime in Salmonella typhimurium and mammalian cells. J Cancer Res Clin Oncol (1988) 0.78
Ligase chain reaction (LCR) assay for semi-quantitative detection of HBV DNA in mononuclear leukocytes of patients with chronic hepatitis B. J Viral Hepat (1996) 0.78
Mouse Elberfeld (ME) virus determines the cell surface alterations when mixedly infecting poliovirus-infected cells. J Gen Virol (1982) 0.77
Pseudorabies in man. Lancet (1987) 0.77
Differences in the morphology of herpes simplex virus infected cells. II. Type specific membrane alterations of HSV-1 and HSV-2 infected cells. Med Microbiol Immunol (1981) 0.77
Hepatitis E in Ireland. Eur J Clin Microbiol Infect Dis (1995) 0.77
Hepatitis E in patients with chronic autoimmune liver disease. JAMA (1995) 0.77